(S)-2-(3-{(S)-3-Carboxy-1-[1-(2-cyano-ethyl)-1H-tetrazol-5-yl]-propyl}-ureido)-pentanedioic acid

ID: ALA301575

Chembl Id: CHEMBL301575

PubChem CID: 11395389

Max Phase: Preclinical

Molecular Formula: C14H19N7O7

Molecular Weight: 397.35

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  N#CCCn1nnnc1[C@H](CCC(=O)O)NC(=O)N[C@@H](CCC(=O)O)C(=O)O

Standard InChI:  InChI=1S/C14H19N7O7/c15-6-1-7-21-12(18-19-20-21)8(2-4-10(22)23)16-14(28)17-9(13(26)27)3-5-11(24)25/h8-9H,1-5,7H2,(H,22,23)(H,24,25)(H,26,27)(H2,16,17,28)/t8-,9-/m0/s1

Standard InChI Key:  WONQKJUDEUBCNI-IUCAKERBSA-N

Associated Targets(Human)

NAALAD2 Tchem NAALADase II (20 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 397.35Molecular Weight (Monoisotopic): 397.1346AlogP: -0.89#Rotatable Bonds: 12
Polar Surface Area: 220.42Molecular Species: ACIDHBA: 9HBD: 5
#RO5 Violations: HBA (Lipinski): 14HBD (Lipinski): 5#RO5 Violations (Lipinski): 1
CX Acidic pKa: 2.87CX Basic pKa: CX LogP: -2.06CX LogD: -12.15
Aromatic Rings: 1Heavy Atoms: 28QED Weighted: 0.29Np Likeness Score: -1.30

References

1. Kozikowski AP, Zhang J, Nan F, Petukhov PA, Grajkowska E, Wroblewski JT, Yamamoto T, Bzdega T, Wroblewska B, Neale JH..  (2004)  Synthesis of urea-based inhibitors as active site probes of glutamate carboxypeptidase II: efficacy as analgesic agents.,  47  (7): [PMID:15027864] [10.1021/jm0306226]

Source